Dacomitinib in Combination with chemotherapy is effective in lung adenocarcinoma with rare &lt;i&gt;EGFR&lt;/i&gt; L747P mutation and bone metastases: a case report. The gene discussed is EGFR; the disease is lung adenocarcinoma.